MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Contrast agents for use with computer tomography, radiography and magnetic resonance imaging.

Contrast agent are used to improve the visibility of internal bodily structures in an X-ray based imaging techniques such as computed tomography (CT), radiography (commonly known as X-ray imaging) and magnetic resonance imaging (MRI).

Full description

Contrast agents are used to improve the visibility of internal bodily structures in an X-ray based imaging techniques such as computed tomography (CT), radiography (commonly known as X-ray imaging) and magnetic resonance imaging (MRI).

Contrast agents such as Iopamidol are used in angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, coronary arteriography and ventriculography, pediatric angiocardiography, selective visceral arteriography and aortography, peripheral venography (phlebography) Iopamidol could be also used in adult and pediatric intravenous excretory urography and intravenous adult and pediatric contrast enhancement of computed tomographic (CECT) head and body imaging

Another contrast medium Gadodiamide, used for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. The product provides contrast enhancement and facilitates visualisation of abnormal structures or lesions in various parts of the body including the CNS.

MRI contrast agent Gadopentetate (reference product Magnevist by Bayer Schering Pharma) it is used to assist imaging of blood vessels and of inflamed or diseased tissue where the blood vessels become 'leaky'. It is often used when viewing intracranial lesions with abnormal vascularity or abnormalities in the blood-brain barrier. It is usually injected intravenously.

 

Development status

Registered

Type of business relationship sought

Partners for co-development in the EU and other parts of World.

Licensing contact

Mr. Jaro Matusiewicz
Business Development

Contact directly

Company details

Help S.A

Help Pharmaceuticals S.A. develops generic products and offers services in contract manufacturing. The company also markets finished products in Greece, EU, Middle East.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
ShareVault
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us